CME Group - CME Stock Forecast, Price & News

12 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CME shares.
View CME analyst ratings or view top-rated stocks.

12 Wall Street analysts have issued twelve-month target prices for CME Group's stock. Their CME share price forecasts range from $161.00 to $267.00. On average, they expect the company's stock price to reach $219.83 in the next year. This suggests a possible upside of 18.8% from the stock's current price.
View analysts price targets for CME or view top-rated stocks among Wall Street analysts.

CME Group's stock was trading at $168.16 at the start of the year. Since then, CME stock has increased by 10.0% and is now trading at $185.02.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 26th 2023.
View our CME earnings forecast.

CME Group will be holding an earnings conference call on Wednesday, April 26th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

CME Group Inc. (NASDAQ:CME) announced its quarterly earnings results on Wednesday, February, 8th. The financial services provider reported $1.92 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.90 by $0.02. The financial services provider had revenue of $1.21 billion for the quarter, compared to the consensus estimate of $1.21 billion. CME Group had a net margin of 53.61% and a trailing twelve-month return on equity of 10.43%. CME Group's revenue for the quarter was up 5.3% on a year-over-year basis. During the same period in the previous year, the company earned $1.66 EPS.
Read the conference call transcript.

CME Group declared a quarterly dividend on Thursday, February 2nd. Investors of record on Friday, March 10th will be given a dividend of $1.10 per share on Monday, March 27th. This represents a $4.40 annualized dividend and a yield of 2.38%. The ex-dividend date is Thursday, March 9th. This is an increase from the stock's previous quarterly dividend of $1.00.
Read our dividend analysis for CME.

ETFs with the largest weight of CME Group (NASDAQ:CME) stock in their portfolio include iShares U.S. Broker-Dealers & Securities Exchanges ETF (IAI), Horizon Kinetics Blockchain Development ETF (BCDF), Amplify Transformational Data Sharing ETF (BLOK), Schwab Crypto Thematic ETF (STCE), TrueShares Low Volatility Equity Income ETF (DIVZ), SmartETFs Dividend Builder ETF (DIVS), Capital Link Global Fintech Leaders ETF (KOIN) and VanEck Morningstar ESG Moat ETF (MOTE).

CME Group (NASDAQ:CME) pays an annual dividend of $4.40 per share and currently has a dividend yield of 2.40%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 59.54%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 50.34% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CME.

294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group's stock is owned by a number of retail and institutional investors. Top institutional investors include Geode Capital Management LLC (1.94%), Parnassus Investments LLC (1.18%), Edgewood Management LLC (1.14%), Vontobel Asset Management Inc. (1.06%), Norges Bank (1.01%) and Neuberger Berman Group LLC (0.97%). Insiders that own company stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy Francis Mccourt, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends.

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CME stock can currently be purchased for approximately $185.02.

CME Group (NASDAQ:CME) has a market capitalization of $66.56 billion and generates $5.02 billion in revenue each year. The financial services provider earns $2.69 billion in net income (profit) each year or $7.39 on an earnings per share basis.

The company employs 3,460 workers across the globe.

CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The official website for the company is www.cmegroup.com. The financial services provider can be reached via phone at (312) 930-1000, via email at info@cmegroup.com, or via fax at 312-466-4410.